GO Term | Evidence Code | PMID |
---|---|---|
determination of liver left/right asymmetry | ||
metanephric ascending thin limb development | ||
cellular response to calcium ion | ||
branching involved in ureteric bud morphogenesis | ||
embryonic placenta development |
GO Term | Evidence Code | PMID |
---|---|---|
basal cortex | ||
motile cilium | ||
ciliary basal body | ||
endoplasmic reticulum | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
cytoskeletal protein binding | ||
ATPase binding | ||
monoatomic cation channel activity | ||
calcium channel activity | ||
muscle alpha-actinin binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0080001 | bone disease | |
DOID:0080212 | polycystic kidney disease 4 | |
DOID:0080322 | polycystic kidney disease | |
DOID:0080409 | familial adenomatous polyposis 1 | |
DOID:0090053 | episodic kinesigenic dyskinesia 1 | |
DOID:0110858 | polycystic kidney disease 1 | |
DOID:0110859 | polycystic kidney disease 2 | |
DOID:0110861 | autosomal recessive polycystic kidney disease | |
DOID:10021 | duodenum cancer | |
DOID:10154 | small intestine cancer |
HPO ID | HPO Term |
---|---|
HP:0003259 | Elevated circulating creatinine concentration |
HP:0003596 | Middle age onset |
HP:0003621 | Juvenile onset |
HP:0003676 | Progressive |
HP:0003774 | Stage 5 chronic kidney disease |
HP:0003829 | Typified by incomplete penetrance |
HP:0004944 | Dilatation of the cerebral artery |
HP:0005562 | Multiple renal cysts |
HP:0006254 | Elevated circulating alpha-fetoprotein concentration |
HP:0006557 | Polycystic liver disease |
Disease ID | Disease Name |
---|---|
ORPHA:730 |
|
OMIM:613095 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115042598 | ECHNA16719 | ||
115390817 | SALFA19413 | ||
113479576 | ATHCN09271 | ||
105812714 | PROCO05140 | ||
109062676 | CYPCA25755 | ||
103731748 | NANGA25078 | ||
116444060 | CORMO22151 | ||
115610341 | STRHB19344 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024